Sign In
Free Newsletter
Dismissing the chatter as Pfizer reorganizes itself
The pharmaceutical industry is in a constant state of flux, led by a regular wave of consolidation and occasional spinoffs.
Tax credit is ‘an important carrot’ for early-stage biotechs
Soligenix Inc. hasn't claimed benefits from the Orphan Drug Tax Credit because the pre-revenue company has yet to generate taxable profits.
For generics companies, key to survival is a rapid response time
When William Kennally switched from the brand side of the pharmaceuticals business to generics 13 years ago, his colleagues kidded that he was joining the dark side.
Skiing accident kicks entrepreneur into new career
A dangerous skiing accident at Lake Tahoe propelled Steve Llorens on a new career path — from lawyer to entrepreneur.
Hard to swallow
When NPS Pharmaceuticals received federal approval to sell Gattex earlier this year, it was great news for those who suffer from short-bowel syndrome — a very rare disease.
It also was great news for the Bedminster company, which stands to benefit from $50 million in tax credit for developing this so-called orphan drug.
Coalition plans to demonstrate in support of paid sick-leave requirement
Jersey City Mayor Steven Fulop's sick-leave proposal — under which employers with more than 10 employees must allow both full and part-time workers to accrue five paid sick days a year — is causing a stir well before the measure goes before the city council Wednesday.
Capsugel acquiring Bend Research
Morristown-based dosage solution company Capsugel announced Thursday it will acquire Oregon-based Bend Research.
Sanofi licenses Pozen cardio drugs in deal worth at least 15M
Sanofi U.S. has signed an exclusive licensing agreement with Pozen Inc. to commercialize the pharmaceutical company's investigational cardiovascular drugs, PA8140 and PA32540.
Derma Sciences acquires 7.3 percent of Comvita
Princeton-based advanced wound care company Derma Sciences announced Wednesday it has purchased 2.3 million newly issued common shares of New Zealand-based health and beauty company Comvita Limited for $7 million. The investment amounts to 7.3 percent of outstanding Comvita shares.
Delta Dental names new CEO
Parsippany-based Delta Dental of New Jersey announced Wednesday it named Dennis Wilson its new president and CEO. Wilson is replacing Walter VanBrunt, who is retiring after serving as CEO for the past 15 years.
Rockwood completes 1.96B CeramTec sale
Princeton-based specialty chemicals company Rockwood Holdings Inc. announced Wednesday it has completed its sale of German ceramics producer CeramTec to European private equity firm Cinven for € 1.49 billion ($1.96 billion).
C.R. Bard acquiring Rochester Medical in 262 million deal
C.R. Bard Inc. has agreed to acquire Rochester Medical Inc., a developer and supplier of silicone urinary incontinence and urine drainage products, for about $262 million, or $20 a share.
